The world is full of nasty and deadly diseases, but some of the worst are the ones that turn your own body against you.

Researchers from the Huntington's Disease Center, UCL Queen Square Institute of Neurology, and UK DRI at UCL have taken major ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022.

Mississippi Today and The Fuller Project requested low-risk C-section data from the Mississippi State Department of Health ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

This important study explores the conserved role of IgM in both systemic and mucosal antiviral immunity in teleosts, challenging established views on the differential roles of IgT and IgM. The ...

An important unanswered question is whether rechallenging patients with enfortumab vedotin plus pembrolizumab after prior ICI exposure remains effective. The authors hypothesized that enfortumab ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

A Wirral woman has become one of the first five in the UK to qualify as a consultant biomedical scientist in skin diseases.

A Wirral woman has become one of the first five in the UK to qualify as a consultant biomedical scientist in skin diseases.